Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1527-7755

Journal

More filtering options
  1. Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial.

    Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Lars Hjorth, Michon, J., Lewis, I., Craft, A. & Jürgens, H., 2010, In : Journal of Clinical Oncology. Jul 1, p. 3284-3291

    Research output: Contribution to journalArticle

  2. Surveillance for late effects in childhood cancer survivors

    Landier, W., Skinner, R., Wallace, W. H., Lars Hjorth, Mulder, R. L., Wong, F. L., Yasui, Y., Bhakta, N., Constine, L. S., Bhatia, S., Kremer, L. C. & Hudson, M. M., 2018 Jul 20, In : Journal of Clinical Oncology. 36, 21, p. 2216-2222 7 p.

    Research output: Contribution to journalReview article

  3. Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial.

    Le Deley, M-C., Paulussen, M., Lewis, I., Brennan, B., Ranft, A., Whelan, J., Le Teuff, G., Michon, J., Ladenstein, R., Marec-Bérard, P., van den Berg, H., Lars Hjorth, Wheatley, K., Judson, I., Juergens, H., Craft, A., Oberlin, O. & Dirksen, U., 2014, In : Journal of Clinical Oncology. 32, 23, p. 2440-2448

    Research output: Contribution to journalArticle

  4. Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer.

    Lehmann, S., Bykov, V. J. N., Ali, D., Andrén, O., Cherif, H., Tidefelt, U., Uggla, B., Yachnin, J., Gunnar Juliusson, Moshfegh, A., Paul, C., Wiman, K. G. & Andersson, P-O., 2012, In : Journal of Clinical Oncology. 30, 29, p. 3633-3639

    Research output: Contribution to journalArticle

  5. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

    Hans Lilja, David Ulmert, Thomas Björk, Charlotte Becker, Serio, A. M., Nilsson, J-A., Abrahamsson, P-A., Vickers, A. J. & Berglund, G., 2007, In : Journal of Clinical Oncology. 25, 4, p. 431-436

    Research output: Contribution to journalArticle

  6. Improving Surveillance and Quality of Life of BRCA Mutation Carriers.

    Niklas Loman & Åke Borg, 2010, In : Journal of Clinical Oncology. 28, p. E376-E377

    Research output: Contribution to journalArticle

  7. Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma.

    Ludwig, H., Bolejack, V., Crowley, J., Bladé, J., San Miguel, J., Kyle, R. A., Rajkumar, S. V., Shimizu, K., Ingemar Turesson, Westin, J., Sonneveld, P., Cavo, M., Boccadoro, M., Palumbo, A., Tosi, P., Harousseau, J-L., Attal, M., Barlogie, B., Stewart, A. K. & Durie, B., 2010, In : Journal of Clinical Oncology. 28, p. 1599-1605

    Research output: Contribution to journalArticle

  8. Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.

    Malone, K. E., Begg, C. B., Haile, R. W., Åke Borg, Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., Reiner, A. S., Riedel, E. R., Thomas, D. C., Mellemkjær, L., Lynch, C. F., Boice, J. D., Anton-Culver, H. & Bernstein, J. L., 2010, In : Journal of Clinical Oncology. 28, p. 2404-2410

    Research output: Contribution to journalArticle

Previous 1...3 4 5 6 7 8 9 10 ...12 Next